Oncothyreon Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 72   

Articles published

ONTY 1.73 +0.02 (1.17%)
price chart
Stocks Roundup - Oncothyreon Inc (USA) (NASDAQ:ONTY), SPYGLASS ...
Oncothyreon Inc (USA) (NASDAQ:ONTY)closed latest trading day at $1.71, down-3.39%, on volume of over 673,426shares. Its average trading volume is 833,792shares.
Why Biotech Stocks Jumped? - BioCryst Pharmaceuticals, Inc. (BCRX ...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) and Oncothyreon Inc (USA) (NASDAQ:ONTY) following small-cap stocks higher. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) extended gains as ...
Related articles »  
Stock Talk: Oncothyreon Inc (USA) (NASDAQ:ONTY), Penn West Petroleum Ltd ...
Denver, CO, 09/19/2014, (Avauncer.com) - Oncothyreon Inc (USA)(NASDAQ:ONTY) on Thursday announced that, it will set the prices for its previous underwritten offerings of 10, 000,000 shares on its common Stock at $2.00 per share.
Oncothyreon Inc (USA) (NASDAQ:ONTY) Declares Pricing of Concurrent Public ...  USTrade Voice
Gainers at NASDAQ: VIVUS Inc. (NASDAQ:VVUS), Arena Pharmaceuticals ...  WallStreet Scope
Related articles »  
09/18 Top Gainers: VIVUS, Inc. (NASDAQ:VVUS), Oncothyreon Inc (NASDAQ ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) jumped over 8 percent in the current trading session after the company revealed the pricing of previously reported concurrent but separate underwritten public offerings of its 10 million common shares at $2 per share ...
Related articles »  
Sharp Movers Following News: NII Holdings Inc (NASDAQ:NIHD), Vimicro ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) jumped 7.50% after it declared the pricing of previously announced concurrent but separate underwritten offerings of 10,000,000 shares of its Common Stock at a price to the public of $2.00 per share, for expected ...
Related articles »  
Moving Stocks: Oncothyreon Inc (NASDAQ:ONTY), Baidu Inc (ADR) (NASDAQ ...
Oncothyreon Inc. (NASDAQ:ONTY) announced that Merck KGaA's (MRK) biopharmaceutical business, Merck Serono, developing its antigen-specific cancer immunotherapy, tecemotide (previously known as Stimuvax).
Why These Stocks: Vitamin Shoppe Inc. (NYSE:VSI), Eli Lilly and Co (NYSE:LLY ...  Avauncer
Related articles »  
On Big Move: Penn West Petroleum (PWE), Biostar Pharmaceuticals (BSPM ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) has announced the pricing of the earlier declared concurrent offerings of its Common Stock and Series a Convertible Stock.
Oncothyreon Inc - Market Review
NEW YORK (AVAFIN) -- Options traders were heavily trading options contracts during the market session establishing a new 3-month volume record for shares of Oncothyreon Inc. A total of 3,905 put and 3,020 calls were traded equating to a 1.29 put/call ...
Related articles »  
Big Movers: Oncothyreon (NASDAQ:ONTY), Discovery Communications ...
According to reports, Oncothyreon Inc (USA) (NASDAQ:ONTY) announced the pricing of its concurrent public offering of 10 million shares of preferred and common stock.
Related articles »  
Zacks Lowers Oncothyreon to Neutral (ONTY)
Separately, analysts at Wedbush cut their price target on shares of Oncothyreon from $6.00 to $3.00 in a research note on Tuesday, August 19th.